Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Dorval

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. the role of clinical responseJ-Y Pierga, E Mouret, V Laurence, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Prognostic factors in inflammatory breast cancer and therapeutic implicationsT Palangie, V Mosseri, J Mihura, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1994
High-dose interleukin-2 two days a week for metastatic renal cell carcinoma: a FNCLCC multicenter studyB Escudier, A Ravaud, M Fabbro, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Neoadjuvant chemotherapy in operable breast cancerS M Scholl, B Asselain, T Palangie, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phenotypic and functional analysis of tumour-infiltrating lymphocytes from patients with melanoma and other metastatic cancersC Mathiot, E Robin, A Gey, et al.
Cancer|January 1, 1996
Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patternsX Sastre-Garau, M Jouve, B Asselain, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 1, 1982
[Treatment of leukemias and lymphomas by interferons: II. Phase II of the trial treatment of chronic lymphoid leukemia by human interferon alpha+]J L Misset, G Mathé, J Gastiaburu, et al.
La Clinica Terapeutica|November 28, 1997
First line protracted venous infusion fluorouracil with CisDDP or carboplatine in advanced colorectal cancerE Garcia-Giralt, C Omodei Zorini, P Beuzeboc, et al.
The Journal of Infusional Chemotherapy|January 1, 1995
Randomized trial comparing two different modalities of administration of the same cytotoxic drugs in metastatic breast cancerJ Y Pierga, M Jouve, B Asselain, et al.
La Clinica Terapeutica|May 1, 1994
[Continuous infusion of doxorubicin for 10 days as third-line chemotherapy in metastasized breast tumors. Initial observations]E Garcia-Giralt, C Omodei Zorini, L Ferri, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. the role of clinical responseJ-Y Pierga, E Mouret, V Laurence, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Prognostic factors in inflammatory breast cancer and therapeutic implicationsT Palangie, V Mosseri, J Mihura, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1994
High-dose interleukin-2 two days a week for metastatic renal cell carcinoma: a FNCLCC multicenter studyB Escudier, A Ravaud, M Fabbro, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Neoadjuvant chemotherapy in operable breast cancerS M Scholl, B Asselain, T Palangie, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phenotypic and functional analysis of tumour-infiltrating lymphocytes from patients with melanoma and other metastatic cancersC Mathiot, E Robin, A Gey, et al.
Cancer|January 1, 1996
Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patternsX Sastre-Garau, M Jouve, B Asselain, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 1, 1982
[Treatment of leukemias and lymphomas by interferons: II. Phase II of the trial treatment of chronic lymphoid leukemia by human interferon alpha+]J L Misset, G Mathé, J Gastiaburu, et al.
La Clinica Terapeutica|November 28, 1997
First line protracted venous infusion fluorouracil with CisDDP or carboplatine in advanced colorectal cancerE Garcia-Giralt, C Omodei Zorini, P Beuzeboc, et al.
The Journal of Infusional Chemotherapy|January 1, 1995
Randomized trial comparing two different modalities of administration of the same cytotoxic drugs in metastatic breast cancerJ Y Pierga, M Jouve, B Asselain, et al.
La Clinica Terapeutica|May 1, 1994
[Continuous infusion of doxorubicin for 10 days as third-line chemotherapy in metastasized breast tumors. Initial observations]E Garcia-Giralt, C Omodei Zorini, L Ferri, et al.
Pageof 11